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Background: Selaginella convoluta (Arn.) Spring (Selaginellaceae), commonly known as “jericó”, is a medicinal plant
found in northeastern Brazil. S. convoluta is used in folk medicine as an antidepressant, aphrodisiac, diuretic,
analgesic, anti-inflammatory and it is used to combat amenorrhea, coughing and bleeding. This study was
performed to evaluate the antinociceptive effects of ethanolic extract from S. convoluta in mice exposed to
chemical and thermal models of nociception.
Methods: Preliminary phytochemical analysis of the ethanolic extract was performed. The ethanolic extract from
Selaginella convoluta (Sc-EtOH) was examined for its intraperitoneal (i.p.) antinociceptive activity at the doses of 100,
200 and 400 mg/kg body weight. Acetic acid-induced writhing, formalin injection and hot plate tests were used to
evaluate the antinociceptive activity of Sc-EtOH extract. The rota-rod test was used to evaluate motor coordination.
Results: A preliminary analysis of Sc-EtOH revealed that it contained phenols, steroids, terpenoids and flavonoids. In
the acetic acid-induced writhing test, mice treated with Sc-EtOH (100, 200 and 400 mg/kg, i.p.) exhibited reduced
writhing (58.46, 75.63 and 82.23%, respectively). Secondly, Sc-EtOH treatment (100, 200 and 400 mg/kg, i.p.)
decreased the paw licking time in mice during the first phase of the formalin test (by 44.90, 33.33 and 34.16%,
respectively), as well as during the second phase of the test (by 86.44, 56.20 and 94.95%, respectively). Additionally,
Sc-EtOH treatment at doses of 200 and 400 mg/kg increased the latency time in the hot plate test after 60 and 90
minutes, respectively. In addition, Sc-EtOH did not impair motor coordination.
Conclusion: Overall, these results indicate that Sc-EtOH is effective as an analgesic agent in various pain models.
The activity of Sc-EtOH is most likely mediated via the inhibition of peripheral mediators and central inhibitory
mechanisms. This study supports previous claims of traditional uses for S. convoluta.
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Selaginellaceae Willk. is a distinctive family that includes
the genus Selaginella, which is found worldwide and
comprises approximately 700 [1] to 750 species [2]. Ap-
proximately 270 species of Selaginella are found in
America, and the genus is widely distributed throughout
America, Africa and Europe. In America, Selaginella can
be found from northern Alaska east to Greenland, and* Correspondence: jackson.guedes@univasf.edu.br
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Selaginella are best represented in the Amazon basin,
with 31 species known to grow in that region [1]. Mem-
bers of the Selaginellaceae family are mostly terrestrial,
herbaceous and perennial plants and vary greatly in size,
some small species have stems approximately 3 cm long,
while larger species have stems 50 cm to approximately
1 m long, but under 2 cm tall. Although the Selaginella-
ceae family has a nearly worldwide distribution, it is not
economically significant [2].
Several species of Selaginella are used in traditional
medicine in various countries in the treatment of atd. This is an Open Access article distributed under the terms of the Creative
ommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and
iginal work is properly cited.
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urinary tract infections [5], diabetes [6], hepatitis [7],
cancer and cardiovascular problems [8]. Extracts from
some species of Selaginella have demonstrated anti-
inflammatory [9], anti-spasmodic [10], cytotoxic, imun-
nostimulant, RNA reverse transcriptase inhibitory agents
[11], anti-mutagenic [12], anti-metastatic activity [13]
and anti-hyperglycemic activities [14].
Previous studies involving some species of Selaginella
revealed that this genus is a rich source of steroids [15],
biflavonoids [16], alkaloids [17], secolignans [18], neo-
lignans and caffeoyl derivatives [19]. Other compounds,
such as alkaloidal glycosides, phenylpropanones and lig-
nans, were also reported in some Selaginella species
[20,21].
Selaginella convoluta is a medicinal plant found in
northeastern Brazil commonly known as “jericó”, “mão-
de-sapo” and “mão-fechada”. S. convoluta is used in folk
medicine as an antidepressant [22,23], aphrodisiac, diur-
etic, in the treatment of amenorrhea [24], coughing,
bleeding, increases female fertility [25] as well as anal-
gesic and anti-inflammatory [26].
In our continuing search of the Brazilian Caatinga
for medicinal plants to combine biodiversity conserva-
tion with drug discovery, we have previously demon-
strated the antinociceptive effects of the ethanolic ex-
tract of Amburana cearensis in mice [27], and anti-ulcer
activity of ethanolic extract of Encholirium spectabile in
rodents [28].
To date, there are no reports on the antinociceptive
activity of S. convoluta. Given the extensive use of this
plant in the semi-arid region of Brazil to treat pain and
inflammation, the aim of this study was to evaluate the
antinociceptive activity of the ethanolic extract from
S. convoluta in experimental models of pain in mice.
Methods
Plant material
A sample of S. convoluta was identified by the botanical
specialist André Paviotti Fontana. The entire plant was
collected in July 2009 near the city of Petrolina, state of
Pernambuco, Northeastern Brazil. A voucher specimen
(6440) is deposited at the Herbarium Vale do São Francisco
(HVASF) of the Centro de Referência para Recuperação de
Áreas Degradadas (CRAD-UNIVASF).
Preparation of plant extract
Plant material was dried in an oven at 45°C with air cir-
culation for three days. The dried and powdered plant
(1730 g) was subjected to extraction with 95% EtOH
three times at room temperature. The time of each ex-
traction was 72 h. The extractive solution was concen-
trated under vacuum in a rotavapor to yield 65 g of the
crude extract.Preliminary phytochemical screening
Preliminary phytochemical analysis of the extract was
performed. The presence of alkaloids was determined
with Dragendorff ’s and Mayer’s reagents, flavonoids
were detected with HCl and Mg powder, phenols
were measured with ferric chloride and both steroids
and terpenoids were detected by Liebermann-Burchard
reaction [29].HPLC-DAD analysis of phenolic compounds
The analysis of the phenolic compound profile of the ex-
tract was performed with liquid chromatography on a
Hitachi model Lachrom Elite HPLC system. The column
was a LiCospher 100 RP18 (5 mm) with dimensions
(150 mm × 04 mm) Merck equipped with a Diode Array
Detector (DAD). The mobile phase consisted of solutions
of H2O/H3PO4 0.1% (A) and MeOH (B), and 75% of A
and 25% of B was initially run for 25 minutes. The column
temperature was maintained at 30°C with a flow rate of
1.0 ml/min. An injection volume of 20 μl of the extract
was used. Spectral data were recorded in 320 nm through-
out the entire procedure.Animals
Adult male albino Swiss mice (35–40 g) were used
throughout this study. The animals were randomly
housed in appropriate cages at 22 ± 2°C on a 12 h light/
dark cycle with free access to food and water. When
necessary, animals were deprived of food 12 h prior to
the experiments. Mice were used in groups of six or ten
animals each, according to the requirements of individual
experiments. The same visual observer performed all
nociception tests, and efforts were made to minimise the
number of animals used, as well as any discomfort to the
animals. Experimental protocols and procedures were
approved by the Universidade Federal do Vale do São
Francisco Animal Care and Use Committee by number
024240408.Pharmacological tests
Acute toxicity
To determine the acute toxicity of the extract, the crude
ethanolic extract of S. convoluta (Sc-EtOH) was admi-
nistered intraperitoneally (2.0 g/kg) and 5.0 g/kg orally
to groups of male (n = 10). The control group received
vehicle. Mortality within 72 h was recorded for each
group, and the animals then were observed for 7 days
for signs of toxicity (body weight variation, consumption
of food and water, piloerection, palpebral ptosis, locomo-
tion and muscular tone alterations, trembling, paw par-
alysis, sedation, ambulation reduction, response to touch
and defecation).
de Sá et al. BMC Complementary and Alternative Medicine 2012, 12:187 Page 3 of 7
http://www.biomedcentral.com/1472-6882/12/187Acetic acid-induced writhing test
This test was performed using the method described by
Koster et al. [30]. Mice were divided into six groups of
six mice each. Acetic acid (0.9% v/v) was administered
i.p. in a volume of 0.1 ml/10 g. Vehicle (saline), mor-
phine (10 mg/kg), acetylsalicylic acid (ASA 150 mg/kg)
and Sc-EtOH (100, 200 and 400 mg/kg), were adminis-
tered i.p. 30 min before the injection of acetic acid. The
number of abdominal constrictions produced in each
group for 10 min post-injection was counted and com-
pared to the response in the control group. Antinocicep-
tive activity was calculated as the percentage inhibition
of abdominal constriction.
Formalin test
The method used was similar to that described by
Hunskaar and Hole [31] and Vianna et al. [32]. Twenty
microliters of 2.5% formalin (in 0.9% saline, subplantar)
was injected subcutaneously into the right hind paw of
the mice. The time (in seconds) spent licking and biting
the injected paw was measured as an indicator of pain
response. Responses were measured for 5 min after for-
malin injection (first phase, neurogenic) and 15–30 min
after formalin injection (second phase, inflammatory).
Vehicle (saline), morphine (10 mg/kg), acetylsalicylic
acid (ASA 150 mg/kg) and Sc-EtOH (100, 200 and
400 mg/kg) were administered i.p. 60 min before the in-
jection of formalin. Mice were observed in the chambers
with a mirror mounted on three sides to allow view of
all of the paws. Antinociceptive activity was calculated
as the percentage inhibition of licking time.
Hot plate test
Mice were divided into five groups of six mice each.
Mice were pre-selected on the hot plate at 55 ± 0.5°C.
Licks on the rear paws were the parameters of observa-
tion. Animals showing a reaction time (defined as the la-
tency for licking the hind feet or jumping) greater than
20 s were discarded. The animals were then treated with
vehicle (saline, 0.1 ml/10 g, i.p.), morphine (10 mg/kg,
i.p.) and Sc-EtOH (100, 200 and 400 mg/kg, i.p.). Latency
time (in seconds) for each mouse was determined on the
hot plate during a maximum period of 20 s, at intervals
of 30, 60, 90 and 120 min after the administration of the
vehicle, extract and morphine [33].
Motor coordination test (Rota-rod test)
A rota-rod tread mill device (Insight, Brazil) was used
for the evaluation of motor coordination [34]. Initially,
24 h before the test, mice capable of remaining on the
rota-rod apparatus longer than 180 s (7 rpm) were
selected. Thirty minutes after the administration of either
Sc-EtOH (100, 200 and 400 mg/kg, i.p.), vehicle (saline/
Tween 80 0.2%; control group) or diazepam (DZP;2.5 mg/kg, i.p.), each animal was tested on the rota-rod
apparatus at 0.5, 1 and 2 h post-treatment, and the time
(s) the mice were able to remain on top of the bar was
recorded for up to 180 s.Statistical analysis
The data are expressed as the means ± S.E.M., and statis-
tical significance was determined using an analysis of
variance (ANOVA) followed by Dunnett’s test. Values
were considered significant at p < 0.05. All analysis was
performed with the GraphPad Prism 4.0 program
(GraphPad Prism Software, Inc., SanDiego, CA, USA).Results
Preliminary phytochemical screening
Preliminary analysis demonstrated that Sc-EtOH was
positive for the presence of phenols, steroids, terpenoids
and flavonoids. However, the ethanolic extract was nega-
tive for the presence of alkaloids.HPLC-DAD analysis of phenolic compounds
The phenolic profile for Sc-EtOH at 320 nm is presented
in Figure 1. The chromatogram shows the presence of a
single peak with a retention time of 19.41 minutes. The
compound has a UV band characteristic of flavonoids.
This compound is under investigation, but in the litera-
ture review, it is reported that the plant biflavonoid
amentoflavone is the major chemical constituent in
different species of the genus Selaginella [35].Acute toxicity
During the evaluation for acute toxicity of Sc-EtOH,
neither 2.0 g/kg intraperitoneally injected or 5.0 g/kg
of orally administered Sc-EtOH resulted in death or
any behavioral and/or physiological alterations, indicat-
ing that the extract has low toxicity. Further studies
will be performed to confirm the absence of acute and
chronic toxicity through histopathological analysis and
determination of the haematological and biochemical
parameters of blood.Acetic acid-induced writhing test
The intraperitoneal administration of Sc-EtOH (100, 200
and 400 mg/kg) had a dose-dependent antinociceptive
effect and significantly decreased the number of writhing
movements induced by the i.p. administration of the
acetic acid compared with the control group (p < 0.01).
The percentages of inhibition were 58.46, 75.63 and
82.23% for Sc-EtOH doses of 100, 200 and 400 mg/kg,
respectively. Acetylsalicylic acid caused an 88.68% reduc-
tion in writhing movements, while morphine abolished
all of the nociceptive responses (Figure 2).
Figure 1 HPLC-DAD phenolic profile for the Sc-EtOH recorded at 320 nm.
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The results of the formalin test are shown in Figures 3
and 4. Sc-EtOH had a significant antinociceptive effect
in decreasing the paw licking time in both the neuro-
genic and inflammatory phases of the test, but the
reduction was most significant in the second phase.
Sc-EtOH administration at 100, 200 and 400 mg/kg,
i.p. decreased the paw licking time by 44.90, 33.33 and
34.16%, respectively, in the first phase and by 86.44,
56.20 and 94.95%, respectively, in the second phase of

























Figure 2 Effect of ethanolic extract of the Selaginella convoluta
(Sc-EtOH), acetylsalicylic acid (ASA 150 mg/kg) and morphine
(Morph 10 mg/kg) on acetic acid induced writhing test. Values
are mean ± S.E.M. **p < 0.01, significantly different from control;
ANOVA followed Dunnett’s test (n = 6, per group).acid, was effective only in the second phase (67.83%).
Morphine decreased the licking time during both
phases.Hot plate test
Figure 5 shows the results of the hot plate test. Sc-EtOH
increased the latency time at doses of 200 and 400 mg/
kg after 60 and 90 minutes, respectively. The effect of























Figure 3 Effect of ethanolic extract of Selaginella convoluta
(Sc-EtOH), acetylsalicylic acid (ASA 150 mg/kg) and morphine
(Morph 10 mg/kg) on formalin test (first phase). Values are
mean ± S.E.M.; **p < 0.01, significantly different from control; ANOVA
followed Dunnett’s test (n = 6, per group).























Figure 4 Effect of ethanolic extract of Selaginella convoluta
(Sc-EtOH), acetylsalicylic acid (ASA 150 mg/kg) and morphine
(Morph 10 mg/kg) on formalin test (second phase). Values are
mean ± S.E.M.; *p < 0.05, **p < 0.01, significantly different from
control; ANOVA followed Dunnett’s test (n = 6, per group).
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In this test, Sc-EtOH did not impair motor coordin-
ation at 0.5, 1 and 2 h post-administration. Diazepam
(2.5 mg/kg) caused a significant decrease in time that
the animals remained on the rota-rod apparatus, com-
pared to the control group (Figure 6).Discussion
The present study is the first time to demonstrate the
antinociceptive activity of S. convoluta in classical
pharmacological models of pain. Although S. convoluta
is widely used in the folk medicine in the semi-arid region
of Brazil, no report about the antinociceptive activity of
this plant is recorded in the literature. The study of plant
species that traditionally have been used for the relief of
the pain should still be seen as a logical research strategy





















Figure 5 Effect of ethanolic extract of Selaginella convoluta (Sc-EtOH)
*p < 0.05, **p < 0.01, significantly different from control; ANOVA followed DThe first test to evaluate the antinociceptive activity of
Sc-EtOH was the acetic acid-induced writhing test. The
intraperitoneal administration of agents that irritate ser-
ous membranes provokes a stereotyped behaviour in the
mice which is characterised by abdominal contractions,
movements of the body as a whole and twisting of the
dorso-abdominal muscles. This method has the advan-
tage of detecting effects produced by weak analgesics.
However, the writhing test is a non-specific method for
evaluation of pain [37]. In this model pain is generated
indirectly via endogenous mediators suck as bradykinin,
serotonin and capsaicin, which stimulate peripheral
nociceptive neurons. The release of arachidonic acid
metabolites via cyclooxygenase and prostaglandin bio-
synthesis are also involved. Sc-EtOH administration sig-
nificantly reduced acetic acid-induced writhing in mice.
This result supports the hypothesis that the extract from
S. convoluta may act by inhibiting prostaglandin synthe-
sis because the nociceptive mechanism of abdominal
writhing induced by acetic acid involves the release of
arachidonic acid metabolites via cyclooxygenase (COX),
and prostaglandin biosynthesis [38]. Additionally, differ-
ent flavonoids have been found to be antinociceptive
and anti-inflammatory agents due to their ability to in-
hibit arachidonic acid metabolism [39-41]. Therefore, it
is possible that the presence of flavonoids in the extract
of S. convoluta may be responsible for the antinocicep-
tive effect. A positive result with this test is indicative of
antinociceptive activity in the Sc-EtOH extract, although
it remained to be determined whether this activity is of
central or peripheral origin.
To distinguish between the central and peripheral anti-
nociceptive action of Sc-EtOH, the formalin test was per-
formed. This test is believed to represent a significant
model of clinical pain [42] that involves two distinct
phases. The initial phase, neurogenic pain, occurs approxi-
mately 3 min after the injection. Then, after a quiescent
period, a second phase, inflammatory pain, occurs be-







and morphine on hot plate test. Values are mean ± S.E.M.;


























Figure 6 Effect of ethanolic extract of Selaginella convoluta (Sc-EtOH) and diazepam (DZP) on rota-rod test. Values are mean ± S.E.M.;
**p < 0.01, significantly different from control; ANOVA followed Dunnett’s test (n = 6, per group).
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whereas the second phase involves a period of sensitisa-
tion during which inflammatory phenomena occur [37]. In
this experiment, Sc-EtOH decreased the licking time in
both phases, but the effect was more significant in the sec-
ond phase. A decrease in licking time in both phases is
characteristic of drugs that act centrally and indicates a
possible interaction with opioid receptors. Opioid analge-
sics seem to be antinociceptive for both phases, although
the first phase is more sensitive to these substances. In
contrast, NSAIDs, such as indomethacin and acetylsali-
cylic acid, seem to suppress only the second phase [31]. In
the formalin test, peripheral inflammatory processes are
involved in the second phase. The effect of the extract in
this phase indicates that the extract has a possible anti-
inflammatory effect.
The evaluation of Sc-EtOH administration with the
hot plate showed that the extract presented effect in the
hot plate test. The extract increased the latency time at
doses of 200 and 400 mg/kg after 60 and 90 minutes, re-
spectively. As the hot plate test is a specific central anti-
nociceptive test, it is possible that Sc-EtOH exerts an
antinociceptive effect at least in part through central
mechanisms. This result is similar to what was observed
in the formalin test with Sc-EtOH inhibiting of both
phases of nociception.
Finally, to assess whether Sc-EtOH produces a loss of
motor coordination in animals, a rota-rod test was per-
formed. The result revealed that the extract did not pro-
duce changes in motor coordination of treated animals.
Conclusion
It can be concluded that Sc-EtOH is effective as an anal-
gesic agent in various pain models. The antinociceptive
effect of Sc-EtOH is most likely mediated via inhibition
of peripheral mediators and central inhibitory mechan-
isms. Our results support that Selaginella convoluta has
therapeutic potential for the treatment of painful disor-
ders. Further studies that are currently in progress willenable us to understand the precise mechanisms of
action of Sc-EtOH.
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